These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22235334)

  • 21. HIV incidence estimation using the BED capture enzyme immunoassay: systematic review and sensitivity analysis.
    Bärnighausen T; McWalter TA; Rosner Z; Newell ML; Welte A
    Epidemiology; 2010 Sep; 21(5):685-97. PubMed ID: 20699682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV incidence in rural South Africa: comparison of estimates from longitudinal surveillance and cross-sectional cBED assay testing.
    Bärnighausen T; Wallrauch C; Welte A; McWalter TA; Mbizana N; Viljoen J; Graham N; Tanser F; Puren A; Newell ML
    PLoS One; 2008; 3(11):e3640. PubMed ID: 18982059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence.
    Moyo S; LeCuyer T; Wang R; Gaseitsiwe S; Weng J; Musonda R; Bussmann H; Mine M; Engelbrecht S; Makhema J; Marlink R; Baum MK; Novitsky V; Essex M
    AIDS Res Hum Retroviruses; 2014 Jan; 30(1):29-36. PubMed ID: 23937344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving Biomarker-based HIV Incidence Estimation in the Treatment Era.
    Fellows IE; Hladik W; Eaton JW; Voetsch AC; Parekh BS; Shiraishi RW
    Epidemiology; 2023 May; 34(3):353-364. PubMed ID: 36863062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort.
    Hauser A; Santos-Hoevener C; Meixenberger K; Zimmermann R; Somogyi S; Fiedler S; Hofmann A; Bartmeyer B; Jansen K; Hamouda O; Bannert N; Kuecherer C
    PLoS One; 2014; 9(6):e98038. PubMed ID: 24892795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating the BED capture enzyme immunoassay to estimate HIV incidence among adults in three countries in sub-Saharan Africa.
    Kim AA; McDougal JS; Hargrove J; Rehle T; Pillay-Van Wyk V; Puren A; Ekra A; Borget-Alloue MY; Adje-Toure C; Abdullahi AS; Odawo L; Marum L; Parekh BS
    AIDS Res Hum Retroviruses; 2010 Oct; 26(10):1051-61. PubMed ID: 20849299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 incidence estimates using IgG-capture BED-enzyme immunoassay from surveillance sites of injection drug users in three cities of China.
    Jiang Y; Wang M; Ni M; Duan S; Wang Y; Feng J; Xiao Y; Dong Y; Wang D; Han M; Xiang L; Ma L; Zhou Q
    AIDS; 2007 Dec; 21 Suppl 8():S47-51. PubMed ID: 18172391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay.
    Hu DJ; Vanichseni S; Mock PA; Young NL; Dobbs T; Byers RH; Choopanya K; van Griensven F; Kitayaporn D; McDougal JS; Tappero JW; Mastro TD; Parekh BS
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):727-30. PubMed ID: 14585202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statistical power and estimation of incidence rate ratios obtained from BED incidence testing for evaluating HIV interventions among young people.
    Auvert B; Mahiane GS; Lissouba P; Moreau T
    PLoS One; 2011; 6(8):e21149. PubMed ID: 21853019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa.
    Karita E; Price M; Hunter E; Chomba E; Allen S; Fei L; Kamali A; Sanders EJ; Anzala O; Katende M; Ketter N;
    AIDS; 2007 Feb; 21(4):403-8. PubMed ID: 17301558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the bed capture enzyme immunoassay useful for surveillance in concentrated epidemics? The case of female sex workers in Indonesia.
    Morineau G; Magnani R; Nurhayati A; Bollen L; Mustikawati DE
    Southeast Asian J Trop Med Public Health; 2011 May; 42(3):634-42. PubMed ID: 21706941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of BED HIV-1 incidence assay in seroconverter cohorts: effect of individuals with long-term infection and importance of stable incidence.
    McNicholl JM; McDougal JS; Wasinrapee P; Branson BM; Martin M; Tappero JW; Mock PA; Green TA; Hu DJ; Parekh B;
    PLoS One; 2011 Mar; 6(3):e14748. PubMed ID: 21408214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decision tree for accurate infection timing in individuals newly diagnosed with HIV-1 infection.
    Verhofstede C; Fransen K; Van Den Heuvel A; Van Laethem K; Ruelle J; Vancutsem E; Stoffels K; Van den Wijngaert S; Delforge ML; Vaira D; Hebberecht L; Schauvliege M; Mortier V; Dauwe K; Callens S
    BMC Infect Dis; 2017 Nov; 17(1):738. PubMed ID: 29187159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends of HIV-1 incidence with credible intervals in Sweden 2002-09 reconstructed using a dynamic model of within-patient IgG growth.
    Romero-Severson EO; Lee Petrie C; Ionides E; Albert J; Leitner T
    Int J Epidemiol; 2015 Jun; 44(3):998-1006. PubMed ID: 26163684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Better control of early viral replication is associated with slower rate of elicited antiviral antibodies in the detuned enzyme immunoassay during primary HIV-1C infection.
    Novitsky V; Wang R; Kebaabetswe L; Greenwald J; Rossenkhan R; Moyo S; Musonda R; Woldegabriel E; Lagakos S; Essex M
    J Acquir Immune Defic Syndr; 2009 Oct; 52(2):265-72. PubMed ID: 19525854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statistical considerations for cross-sectional HIV incidence estimation based on recency test.
    Gao F; Bannick M
    Stat Med; 2022 Apr; 41(8):1446-1461. PubMed ID: 34984710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual testing algorithm of BED-CEIA and AxSYM Avidity Index assays performs best in identifying recent HIV infection in a sample of Rwandan sex workers.
    Braunstein SL; Nash D; Kim AA; Ford K; Mwambarangwe L; Ingabire CM; Vyankandondera J; van de Wijgert JH
    PLoS One; 2011 Apr; 6(4):e18402. PubMed ID: 21532753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in Botswana.
    Moyo S; Vandormael A; Wilkinson E; Engelbrecht S; Gaseitsiwe S; Kotokwe KP; Musonda R; Tanser F; Essex M; Novitsky V; de Oliveira T
    PLoS One; 2016; 11(8):e0160649. PubMed ID: 27552218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the statistical accuracy of biomarker assays for HIV incidence.
    Brookmeyer R
    J Acquir Immune Defic Syndr; 2010 Aug; 54(4):406-14. PubMed ID: 20436353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.